Yu-Lun Lo1,2, Yung-Lun Ni1,3, Tsai-Yu Wang1, Ting-Yu Lin1, Hsueh-Yu Li4, David P White5, Jr-Rung Lin6, Han-Pin Kuo1. 1. Department of Thoracic Medicine, Chang Gung Memorial Hospital, Chang Gung University, School of Medicine, Taipei, Taiwan. 2. Healthcare Center, Chang Gung Memorial Hospital, Taipei, Taiwan. 3. Department of Chest Medicine, Taichung Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taichung, Taiwan. 4. Department of Otolaryngology, Chang Gung Memorial Hospital, Chang Gung University, School of Medicine, Taipei, Taiwan. 5. Division of Sleep Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA. 6. Clinical Informatics and Medical Statistics Research Center, Chang Gung University, School of Medicine, Taipei, Taiwan.
Abstract
OBJECTIVE: To evaluate the effect of sedation depth on drug-induced sleep endoscopy (DISE). METHODS: Ninety patients with obstructive sleep apnea (OSA) and 18 snorers underwent polysomnography and DISE under bispectral index (BIS)-guided propofol infusion at two different sedation levels: BIS 65-75 (light sedation) and 50-60 (deep sedation). RESULTS: For the patients with OSA, the percentages of velopharynx, oropharynx, hypopharynx, and larynx obstructions under light sedation were 77.8%, 63.3%, 30%, and 33.3%, respectively. Sedation depth was associated with the severity of velopharynx and oropharynx obstruction, oropharynx obstruction pattern, tongue base obstruction, epiglottis anteroposterior prolapse and folding, and arytenoid prolapse. In comparison, OSA severity was associated with the severity of velopharynx obstruction, severity of oropharynx obstruction, and arytenoid prolapse (odds ratio (95% confidence interval); 14.3 (4.7-43.4), 11.7 (4.2-32.9), and 13.2 (2.8-62.3), respectively). A good agreement was noted between similar DISE findings at different times and different observers (kappa value 0.6 to 1, respectively). A high percentage of arytenoid prolapse (46.7% among the patients with OSA under light sedation) was noted. CONCLUSIONS: Greater sedative depth increased upper airway collapsibility under DISE assessment. DISE under BIS-guided propofol infusion, and especially a level of 65-75, offers an objective and reproducible method to evaluate upper airway collapsibility. Some findings were induced by drug sedation and need careful interpretation. Specific arytenoid prolapse patterns were noted for which further investigations are warranted. CLINICAL TRIALS REGISTRATION: http://www.clinicaltrials.gov, identifier: NCT01100554. COMMENTARY: A commentary on this article appears in this issue on page 965.
OBJECTIVE: To evaluate the effect of sedation depth on drug-induced sleep endoscopy (DISE). METHODS: Ninety patients with obstructive sleep apnea (OSA) and 18 snorers underwent polysomnography and DISE under bispectral index (BIS)-guided propofol infusion at two different sedation levels: BIS 65-75 (light sedation) and 50-60 (deep sedation). RESULTS: For the patients with OSA, the percentages of velopharynx, oropharynx, hypopharynx, and larynx obstructions under light sedation were 77.8%, 63.3%, 30%, and 33.3%, respectively. Sedation depth was associated with the severity of velopharynx and oropharynx obstruction, oropharynx obstruction pattern, tongue base obstruction, epiglottis anteroposterior prolapse and folding, and arytenoid prolapse. In comparison, OSA severity was associated with the severity of velopharynx obstruction, severity of oropharynx obstruction, and arytenoid prolapse (odds ratio (95% confidence interval); 14.3 (4.7-43.4), 11.7 (4.2-32.9), and 13.2 (2.8-62.3), respectively). A good agreement was noted between similar DISE findings at different times and different observers (kappa value 0.6 to 1, respectively). A high percentage of arytenoid prolapse (46.7% among the patients with OSA under light sedation) was noted. CONCLUSIONS: Greater sedative depth increased upper airway collapsibility under DISE assessment. DISE under BIS-guided propofol infusion, and especially a level of 65-75, offers an objective and reproducible method to evaluate upper airway collapsibility. Some findings were induced by drug sedation and need careful interpretation. Specific arytenoid prolapse patterns were noted for which further investigations are warranted. CLINICAL TRIALS REGISTRATION: http://www.clinicaltrials.gov, identifier: NCT01100554. COMMENTARY: A commentary on this article appears in this issue on page 965.
Authors: Fábio A W Rabelo; Daniel S Küpper; Heidi H Sander; Regina M F Fernandes; Fabiana C P Valera Journal: Laryngoscope Date: 2013-06-25 Impact factor: 3.325
Authors: Elizabeth L Whitlock; Alexander J Villafranca; Nan Lin; Ben J Palanca; Eric Jacobsohn; Kevin J Finkel; Lini Zhang; Beth A Burnside; Heiko A Kaiser; Alex S Evers; Michael S Avidan Journal: Anesthesiology Date: 2011-12 Impact factor: 7.892
Authors: Ryan C Borek; Erica R Thaler; Christopher Kim; Nicholas Jackson; Jeff E Mandel; Richard J Schwab Journal: Laryngoscope Date: 2012-09-10 Impact factor: 3.325
Authors: M M Sahinovic; U Beese; E H Heeremans; A Kalmar; K van Amsterdam; R J H M Steenbakkers; H Kuiper; R Spanjersberg; R J M Groen; M M R F Struys; A R Absalom Journal: Br J Anaesth Date: 2013-10-31 Impact factor: 9.166
Authors: Fabio Augusto Winckler Rabelo; Daniel Salgado Küpper; Heidi Haueisen Sander; Vanier dos Santos Júnior; Eric Thuler; Regina Maria França Fernandes; Fabiana Cardoso Pereira Valera Journal: Braz J Otorhinolaryngol Date: 2013 Jan-Feb
Authors: Patrick Kellner; Beatrice Herzog; Sebastian Plößl; Christian Rohrmeier; Thomas Kühnel; Ramona Wanzek; Stefan Plontke; Michael Herzog Journal: Sleep Breath Date: 2016-04-25 Impact factor: 2.816
Authors: Claudio Vicini; Andrea De Vito; Giannicola Iannella; Riccardo Gobbi; Ruggero Massimo Corso; Filippo Montevecchi; Antonella Polimeni; Marco De Vincentiis; Giuseppe Meccariello; Giovanni D'agostino; Giovanni Cammaroto; Francesco Stomeo; Giuseppe Magliulo Journal: Eur Arch Otorhinolaryngol Date: 2018-10-13 Impact factor: 2.503